Accelerated Invisalign Therapy in Conjunction With Acceledent Aura

NCT ID: NCT02868554

Last Updated: 2020-01-27

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-31

Study Completion Date

2019-04-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose:

The objective of this study is to investigate the effects of accelerated Invisalign and vibration therapy on rate of orthodontic tooth movement, activation of inflammation biomarkers as well as pain levels experienced by orthodontic patients during the initial 12 weeks of alignment.

Participants:

Up to 30 orthodontic patients of the University of North Carolina Orthodontic Residency Program will be recruited for this study. Patients older than 18 years old will be otherwise healthy subjects previously diagnosed with malocclusion.

Procedures (methods):

Each patient will be randomly allocated into either a control group or one of two intervention groups. Patients within the control group will receive standard Invisalign therapy without vibration. Patients within the intervention groups will receive accelerated Invisalign therapy with or without vibration. Patients receiving vibration therapy will utilize an AcceleDent Aura device which provides a light vibration at .25 Newtons (N) and 30 Hertz (Hz) frequency for twenty minutes daily. Three dimensional images of each subject's dentition will be recorded five times at 0 days, 4 days, 2 weeks, 6 weeks, and 12 weeks progress visits.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Align Technology©, Inc. developed Invisalign® in 1997 to meet the esthetic demands of orthodontic patients and providers. Invisalign patients receive a series of computer-assisted designed stereolithic clear retainers to incrementally resolve their malocclusion. Invisalign® and other advances in orthodontic technology such as clear aligners, ceramic brackets and lingual braces offer options to address the esthetic demands of most orthodontic patients but duration of treatment continues to be one of the most challenging aspects of practice.

In 2008, OrthoAccel Technologies©, Inc. developed the AcceleDent device to accelerate tooth movement and reduce orthodontic treatment time. Patients receiving vibration therapy are instructed to bite down on the AcceleDent mouthpiece, which vibrates at a .25 N (25 grams) force level with a 30 Hz frequency for 20 minutes per day. The theory underlying AcceleDent and the use of vibration to expedite orthodontic tooth movement started in 1892 with the studies of Julius Wolff, who discovered bone adapts to pressure loads. In 2001, Astronauts in space attempted to use the principles of Wolff's Law to maintain normal bone quality by working out and performing daily tasks while standing on a vibrating plate with the aid of elastic straps. In 2004, the effect of vibration therapy on bone density was further supported when increased bone density and strength was noted in post-menopausal women who received whole body vibration therapy. OrthoAccel claims vibration therapy using the AcceleDent device can reduce treatment time up to 50 percent by accelerating the process of bone remodeling required for orthodontic tooth movement. In 2013, despite relatively little scientific evidence, the US Food and Drug Administration (FDA) approved AcceleDent as a class II medical device and orthodontic accessory to facilitate accelerated tooth movement.

Invisalign therapy in conjunction with AcceleDent has been aggressively marketed towards the esthetically sensitive patient who, not so coincidentally, is the most concerned with duration of treatment. Some orthodontic providers using vibration therapy have deviated from the standard 2-week aligner schedule and recommend a 4-day aligner schedule. Orthodontic patients receiving accelerated Invisalign therapy in conjunction with AcceleDent claim reduced treatment time by as much as 50 percent. What is responsible for the positive results? The accelerated tooth movement might simply be the result of the accelerated Invisalign therapy, which would raise the question of whether vibration therapy and the cost associated with AcceleDent is justified. The purpose and primary specific aim of our study will be to determine the cause of the accelerated tooth movement. Because the vibration therapy is used in conjunction with an accelerated Invisalign aligner schedule, there is an assumption that the vibration therapy is promoting faster tooth movement. However, the current literature, from clinical trials, supporting the efficacy of vibration therapy on accelerated tooth movement is lacking.

Accelerated orthodontic tooth movement may offer many benefits to both, the patient and the orthodontist. Reduced treatment time reduces the burden of orthodontic treatment by decreasing risk for undesired treatment sequelae (e.g., white spot lesion, caries, gingivitis, etc) and potentially reduces the discomfort commonly associated with orthodontic treatment. Orthodontists benefit from accelerated tooth movement for multiple reasons pertaining to practice management and increased profitability. Orthodontists using accelerated treatment techniques have reported increased profit margins due to reduced chair time and increased organic growth due to differentiation of the practice.

There are also potential negative outcomes associated with accelerated orthodontic tooth movement. For the patient, there is a potential increased risk for root resorption, increased treatment fees and pain associated with treatment. At this time, there is no published data regarding the potential for orthodontic relapse following the accelerated orthodontic tooth movement. There are several publications supporting the fact that relapse is a known risk for conventional orthodontic treatment. The investigators can make the safe assumption that accelerated orthodontic treatment would be no different than conventional orthodontic therapy with regard to relapse potential. All orthodontic patients must be compliant with regard to orthodontic retention or relapse will be expected. Most orthodontists are charging between $700-800 for AcceleDent therapy in addition to the normal orthodontic fee. Finally, there is no published data regarding pain associated with accelerated Invisalign treatment.

Further, the mechanism underlying any increased orthodontic tooth movement due to vibration remains unclear. Studies on a cellular level have shown a promising but complicated mechanism of how vibration may enhance activation of various cell proliferation and differentiation molecules within the periodontal ligament (PDL) stem cells as well as increase levels of gingival inflammation biomarkers. For example, vibration therapy might accelerate breakdown of the cellular cytoskeleton, increase actinG trafficking into the nucleus, increase Runx2 gene expression, and thus facilitate bone formation. Whether this mechanotransduction mechanism can be translated into clinical tooth movement is unknown and its clinical evidence remains to be elucidated.

In this study, the investigators propose a randomized prospective clinical design to investigate effects of AcceleDent vibration therapy on the efficiency of tooth movement, on the activation of gingival crevicular fluid biomarkers and on patient discomfort in conjunction with accelerated Invisalign therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malocclusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Invisalign Therapy

Patients receiving standard Invisalign therapy will be instructed to wear each aligner 24 hours day. Patients will be permitted to progress to the subsequent aligner after 14 days of compliant aligner wear.

Group Type NO_INTERVENTION

No interventions assigned to this group

Accelerated Invisalign

Patients receiving accelerated Invisalign therapy will be instructed to wear each aligner 24 hours day. Patients will be permitted to progress to the subsequent aligner after 4 days of compliant aligner wear.

Group Type EXPERIMENTAL

Accelerated Invisalign therapy

Intervention Type DEVICE

Patients receiving accelerated Invisalign therapy will be instructed to wear each aligner 24 hours day. Patients will be permitted to progress to the subsequent aligner after 4 days of compliant aligner wear.

Accelerated Invisalign and Vibration

In addition to the accelerated Invisalign protocol described in Arm #2, patients will undergo intraoral vibration therapy using an AcceleDent Aura device for a duration of 20 minutes per day.

Group Type EXPERIMENTAL

AcceleDent Aura

Intervention Type DEVICE

Patients receiving vibration therapy will be instructed to bite down on the AcceleDent mouthpiece, which vibrates at a .25 Newtons (25 grams) force level with a 30 Hertz frequency for 20 minutes per day.

Accelerated Invisalign therapy

Intervention Type DEVICE

Patients receiving accelerated Invisalign therapy will be instructed to wear each aligner 24 hours day. Patients will be permitted to progress to the subsequent aligner after 4 days of compliant aligner wear.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

AcceleDent Aura

Patients receiving vibration therapy will be instructed to bite down on the AcceleDent mouthpiece, which vibrates at a .25 Newtons (25 grams) force level with a 30 Hertz frequency for 20 minutes per day.

Intervention Type DEVICE

Accelerated Invisalign therapy

Patients receiving accelerated Invisalign therapy will be instructed to wear each aligner 24 hours day. Patients will be permitted to progress to the subsequent aligner after 4 days of compliant aligner wear.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Males or females over the age of 18 years old desiring orthodontic treatment.
2. Adult dentition with all upper and lower front teeth present and any premolar and molar combination in the upper posterior of two teeth on each side.
3. Normal pulp vitality and healthy periodontal tissues as determined by intraoral exam.
4. Good health as determined by medical history.
5. Willingness and ability to comply with study procedures, attend study visits, and complete the study.
6. The ability to understand and sign a written informed consent form, which must be signed prior to initiation of study procedures.

Exclusion Criteria

1. Patient under the age of 18 years old
2. Women may not be pregnant. Negative urine pregnancy tests prior to exposure to cone beam imaging is required to verify pregnancy status.
3. Patients diagnosed with systemic diseases such as diabetes, hypertension (high blood pressure), temporomandibular disorders (jaw disorders), or craniofacial syndromes.
4. Severe malocclusions that would require adjunctive procedures other than Invisalign. These include impacted teeth, closure of extractions spaces.
5. Significant periodontal disease (\> 4mm pocket depth or \>2 mm of recession on upper anterior teeth).
6. Active caries not under care of either a dentist or periodontist.
7. Chronic daily use of any non-steroidal anti-inflammatory medication, estrogen, calcitonin, or corticosteroids.
8. History of use or current use of any bisphosphonate medication or other medication for treatment of osteoporosis.
9. Current smoker (must not have smoked in the last 6 months).
10. Failing to comply with research protocols
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

OrthoAccel Technologies Inc.

INDUSTRY

Sponsor Role collaborator

University of North Carolina, Chapel Hill

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ching C Ko, DDS, PhD

Role: PRINCIPAL_INVESTIGATOR

UNC Department of Orthodontics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UNC Department of Orthodontics

Chapel Hill, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Sen B, Xie Z, Uzer G, Thompson WR, Styner M, Wu X, Rubin J. Intranuclear Actin Regulates Osteogenesis. Stem Cells. 2015 Oct;33(10):3065-76. doi: 10.1002/stem.2090.

Reference Type BACKGROUND
PMID: 26140478 (View on PubMed)

Uribe F, Padala S, Allareddy V, Nanda R. Patients', parents', and orthodontists' perceptions of the need for and costs of additional procedures to reduce treatment time. Am J Orthod Dentofacial Orthop. 2014 Apr;145(4 Suppl):S65-73. doi: 10.1016/j.ajodo.2013.12.015.

Reference Type BACKGROUND
PMID: 24680026 (View on PubMed)

Ojima K, Dan C, Nishiyama R, Ohtsuka S, Schupp W. Accelerated extraction treatment with Invisalign. J Clin Orthod. 2014 Aug;48(8):487-99. No abstract available.

Reference Type BACKGROUND
PMID: 25226041 (View on PubMed)

Bowman SJ. The effect of vibration on the rate of leveling and alignment. J Clin Orthod. 2014 Nov;48(11):678-88. No abstract available.

Reference Type BACKGROUND
PMID: 25707947 (View on PubMed)

Orr MF, Ruckart PZ. Surveillance of hazardous substances releases due to system interruptions, 2002. J Hazard Mater. 2007 Apr 11;142(3):754-9. doi: 10.1016/j.jhazmat.2006.06.121. Epub 2006 Jul 3.

Reference Type BACKGROUND
PMID: 16920261 (View on PubMed)

Nishimura M, Chiba M, Ohashi T, Sato M, Shimizu Y, Igarashi K, Mitani H. Periodontal tissue activation by vibration: intermittent stimulation by resonance vibration accelerates experimental tooth movement in rats. Am J Orthod Dentofacial Orthop. 2008 Apr;133(4):572-83. doi: 10.1016/j.ajodo.2006.01.046.

Reference Type BACKGROUND
PMID: 18405822 (View on PubMed)

d'Apuzzo F, Cappabianca S, Ciavarella D, Monsurro A, Silvestrini-Biavati A, Perillo L. Biomarkers of periodontal tissue remodeling during orthodontic tooth movement in mice and men: overview and clinical relevance. ScientificWorldJournal. 2013 Apr 23;2013:105873. doi: 10.1155/2013/105873. Print 2013.

Reference Type BACKGROUND
PMID: 23737704 (View on PubMed)

Meikle MC. The tissue, cellular, and molecular regulation of orthodontic tooth movement: 100 years after Carl Sandstedt. Eur J Orthod. 2006 Jun;28(3):221-40. doi: 10.1093/ejo/cjl001. Epub 2006 May 10.

Reference Type BACKGROUND
PMID: 16687469 (View on PubMed)

Marie SS, Powers M, Sheridan JJ. Vibratory stimulation as a method of reducing pain after orthodontic appliance adjustment. J Clin Orthod. 2003 Apr;37(4):205-8; quiz 203-4. No abstract available.

Reference Type BACKGROUND
PMID: 12747073 (View on PubMed)

Xiong J, O'Brien CA. Osteocyte RANKL: new insights into the control of bone remodeling. J Bone Miner Res. 2012 Mar;27(3):499-505. doi: 10.1002/jbmr.1547.

Reference Type BACKGROUND
PMID: 22354849 (View on PubMed)

Leethanakul C, Suamphan S, Jitpukdeebodintra S, Thongudomporn U, Charoemratrote C. Vibratory stimulation increases interleukin-1 beta secretion during orthodontic tooth movement. Angle Orthod. 2016 Jan;86(1):74-80. doi: 10.2319/111914-830.1. Epub 2015 Mar 26.

Reference Type BACKGROUND
PMID: 25811245 (View on PubMed)

Nimeri G, Kau CH, Abou-Kheir NS, Corona R. Acceleration of tooth movement during orthodontic treatment--a frontier in orthodontics. Prog Orthod. 2013 Oct 29;14:42. doi: 10.1186/2196-1042-14-42.

Reference Type BACKGROUND
PMID: 24326040 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16-0167

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.